Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
The Journal of Organic Chemistry|October 24, 2001
Characterization and Synthesis of a 6-Substituted Benzo[b]thiopheneAnthony R. Haight, Gregory S. Wayne, Gregory S. Lannoye, et al.
The Journal of Clinical Psychiatry|August 10, 2005
Remission rates following antidepressant therapy with bupropion or selective serotonin reuptake inhibitors: a meta-analysis of original data from 7 randomized controlled trialsMichael E Thase, Barbara R Haight, Nathalie Richard, et al.
Lancet (London, England)|February 23, 2019
Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trialBarbara R Haight, Susan M Learned, Celine M Laffont, et al.
Biological Psychiatry|April 12, 2005
Bupropion XL in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled studyTimothy E Wilens, Barbara R Haight, Joseph P Horrigan, et al.
Journal of Clinical Psychopharmacology|April 14, 2020
Treating Opioid Use Disorder With a Monthly Subcutaneous Buprenorphine Depot Injection: 12-Month Safety, Tolerability, and Efficacy AnalysisAnne C Andorn, Barbara R Haight, Sunita Shinde, et al.
The Journal of Organic Chemistry|November 8, 2003
Allylation of erythromycin derivatives: introduction of allyl substituents into highly hindered alcoholsEric J Stoner, Matthew J Peterson, Michael S Allen, et al.
Immunotargets and Therapy|May 27, 2026
Development of an Active Chimeric IL13Rα2 ADC for Diffuse Intrinsic Pontine GliomaXiaolei Lian, Victoria J Allanson, Samuel V Rasmussen, et al.
The Journal of Organic Chemistry|January 11, 2019
Discovery and Development of Metal-Catalyzed Coupling Reactions in the Synthesis of Dasabuvir, an HCV-Polymerase InhibitorDavid M Barnes, Shashank Shekhar, Travis B Dunn, et al.
Physical Review Letters|August 29, 2014
Bright laser-driven neutron source based on the relativistic transparency of solidsM Roth, D Jung, K Falk, et al.
Science Advances|October 4, 2024
BCL-X<sub>L</sub>-targeting antibody-drug conjugates are active in preclinical models and mitigate on-mechanism toxicity of small-molecule inhibitorsAndrew S Judd, Bhupinder Bawa, Wayne R Buck, et al.
Pageof 6